Top

Published in:

01-01-2020 | Astrocytoma | Editorial

Updating the grading criteria for adult diffuse gliomas: beyond the WHO2016CNS classification

Author: Takashi Komori

Published in: Brain Tumor Pathology | Issue 1/2020

Excerpt

The classification of adult diffuse gliomas has shifted from the traditional histogenetic classification to a molecular one in the updated 4th edition of the WHO Classification of Tumours of the Central Nervous System, published in 2016 (WHO2016CNS) [10]. This shift is based on the discovery of isocitrate dehydrogenase (IDH) mutations as the most upstream genetic event in two canonical diffuse glioma lineages: diffuse astrocytomas and oligodendrogliomas of adults (the “molecular era”) [7, 8]. While this revision represents a paradigm shift in brain tumor classification, the grading schemes for diffuse gliomas were not modified simultaneously, as no alternative method that satisfactorily replaces the traditional histological grading approach using morphologic features (i.e. anaplasia, mitosis, microvascular proliferation [MVP] and necrosis has yet been reported). …

Aoki K, Nakamura H, Suzuki H, Matsuo K, Kataoka K, Shimamura T, Motomura K, Ohka F, Shiina S, Yamamoto T et al (2018) Prognostic relevance of genetic alterations in diffuse lower-grade gliomas. Neuro Oncol 20:66–77. https://doi.org/10.1093/neuonc/nox132 CrossRefPubMed

Appay R, Dehais C, Maurage CA, Alentorn A, Carpentier C, Colin C, Ducray F, Escande F, Idbaih A, Kamoun A et al (2019) CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDH-mutant gliomas. Neuro Oncol 21:1519–1528. https://doi.org/10.1093/neuonc/noz124 CrossRefPubMed

Brat DJ, Aldape K, Colman H, Holland EC, Louis DN, Jenkins RB, Kleinschmidt-DeMasters BK, Perry A, Reifenberger G, Stupp R et al (2018) cIMPACT-NOW update 3: recommended diagnostic criteria for "diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV". Acta Neuropathol 136:805–810. https://doi.org/10.1007/s00401-018-1913-0 CrossRefPubMedPubMedCentral

Brat DJ, Aldape K, Colman H, Figrarella-Branger D, Fuller GN, Giannini C, Holland EC, Jenkins RB, Kleinschmidt-DeMasters B, Komori T et al (2020) cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas. Acta Neuropathol. https://doi.org/10.1007/s00401-020-02127-9 CrossRefPubMed

Cancer Genome Atlas Research N, Brat DJ, Verhaak RG, Aldape KD, Yung WK, Salama SR, Cooper LA, Rheinbay E, Miller CR, Vitucci M et al (2015) Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N Engl J Med 372:2481–2498. https://doi.org/10.1056/NEJMoa1402121 CrossRef

Giannini C, Scheithauer BW, Burger PC, Christensen MR, Wollan PC, Sebo TJ (1999) Cellular proliferation in pilocytic and diffuse astrocytomas. J Neuropathol Exp Neurol. https://doi.org/10.1097/00005072-199901000-00006 CrossRefPubMed

Iuchi T, Sugiyama T, Ohira M, Kageyama H, Yokoi S, Sakaida T, Hasegawa Y, Setoguchi T, Itami M (2018) Clinical significance of the 2016 WHO classification in Japanese patients with gliomas. Brain Tumor Pathol 35:71–80. https://doi.org/10.1007/s10014-018-0309-0 CrossRefPubMed

Komori T (2017) The 2016 WHO Classification of Tumours of the Central Nervous System: the major points of revision. Neurol Med Chir (Tokyo) 57:301–311. https://doi.org/10.2176/nmc.ra.2017-0010 CrossRef

Komori T (2019) The anticipated revision of the grading criteria for adult isocitrate dehydrogenase-mutant diffuse glioma within the neuro-oncology community. Neuro Oncol 21:1485–1486. https://doi.org/10.1093/neuonc/noz186 CrossRefPubMed

10.

Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803–820. https://doi.org/10.1007/s00401-016-1545-1 CrossRef

11.

Louis DN, Aldape K, Brat DJ, Capper D, Ellison DW, Hawkins C (2017) Announcing cIMPACT-NOW: the consortium to inform molecular and practical approaches to CNS tumor taxonomy. Acta Neuropathol. https://doi.org/10.1007/s00401-016-1646-x CrossRefPubMed

12.

Olar A, Wani KM, Alfaro-Munoz KD, Heathcock LE, van Thuijl HF, Gilbert MR, Armstrong TS, Sulman EP, Cahill DP, Vera-Bolanos E et al (2015) IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas. Acta Neuropathol 129:585–596. https://doi.org/10.1007/s00401-015-1398-z CrossRefPubMedPubMedCentral

13.

Shirahata M, Ono T, Stichel D, Schrimpf D, Reuss DE, Sahm F, Koelsche C, Wefers A, Reinhardt A, Huang K et al (2018) Novel, improved grading system(s) for IDH-mutant astrocytic gliomas. Acta Neuropathol 136:153–166. https://doi.org/10.1007/s00401-018-1849-4 CrossRefPubMed

14.

Sonoda Y, Yokoo H, Tanaka S, Kinoshita M, Nakada M, Nishihara H, Committee for molecular diagnosis of the Japan Society of Brain Tumor P (2019) Practical procedures for the integrated diagnosis of astrocytic and oligodendroglial tumors. Brain Tumor Pathol 36:56–62. https://doi.org/10.1007/s10014-019-00337-y CrossRefPubMed

15.

Wester K, Wahlund E, Sundstrom C, Ranefall P, Bengtsson E, Russell PJ, Ow KT, Malmstrom PU, Busch C (2000) Paraffin section storage and immunohistochemistry. Effects of time, temperature, fixation, and retrieval protocol with emphasis on p53 protein and MIB1 antigen. Appl Immunohistochem Mol Morphol 8:61–70PubMed

16.

Yang RR, Shi ZF, Zhang ZY, Chan AK, Aibaidula A, Wang WW, Kwan JSH, Poon WS, Chen H, Li WC et al (2019) IDH mutant lower grade (WHO Grades II/III) astrocytomas can be stratified for risk by CDKN2A, CDK4 and PDGFRA copy number alterations. Brain Pathol. https://doi.org/10.1111/bpa.12801 CrossRefPubMed

Title: Updating the grading criteria for adult diffuse gliomas: beyond the WHO2016CNS classification
Author: Takashi Komori
Publication date: 01-01-2020
Publisher: Springer Singapore
Keywords: Astrocytoma
Glioma
Glioma
Astrocytoma
Astrocytoma
Oligodendroglioma
Glioma
Published in: Brain Tumor Pathology / Issue 1/2020
Print ISSN: 1433-7398
Electronic ISSN: 1861-387X
DOI: https://doi.org/10.1007/s10014-020-00358-y

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Updating the grading criteria for adult diffuse gliomas: beyond the WHO2016CNS classification

Excerpt

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content